Assessing the Risk of Commercial Vaccines Against Pseudorabies Virus in Cats

Lu Tu, Jingjie Zhao, Qiuyang Chen, Shan Zhang, Liang Lin, Xinming Tang, Shaohua Hou, Weifang Yang, Ruiying LiangFrontiers in Veterinary Science 2022 · DOI

Abstract

Pseudorabies virus (PRV) is a zoonotic agent that causes significant economic losses in animal husbandry worldwide, and gE-deleted vaccines play an important role in its treatment in the swine industry. However, the potential risk of attenuated PRV strains in commercial vaccines for other hosts remains unclear. Especially, cats are important companion animals for human beings. In this study, we investigated the prevalence and pathogenicity of the PRV wild strain in the cat population. We found that the occurrence of PR diseases in cats is sporadic, that the attenuated PRV strain causes slight clinical signs in cats, and that the virus is excreted 3 days post-infection. Our findings will be beneficial in furthering our understanding of the epidemiology and pathogenicity of PRV in cats and implying the great risk of RPV transmission from pigs to cats.

Introduction

Pseudorabies virus (PRV) is a major threat to the global swine industry. While pigs are the primary reservoir, PRV is known to infect a wide range of hosts—including cattle, dogs, and cats—where it is almost always fatal. To combat this, the industry uses "gE-deleted" attenuated vaccines, such as the Bartha-K61 strain. These vaccines lack the glycoprotein E (gE) gene, allowing for the differentiation between vaccinated and naturally infected animals (the DIVA principle). However, the safety of these attenuated "live" vaccines for non-swine species, particularly cats that often live near pig farms, remains a critical concern. This study investigates whether vaccine strains can jump from pigs to cats and cause disease.

Methods

The researchers conducted a retrospective survey and a challenge study to assess PRV prevalence and pathogenicity in felines.

  1. Retrospective Survey: 54 feline clinical samples (nasal swabs and organs) collected in Guangdong, China (2019-2020) were analyzed using real-time quantitative PCR for gB (present in all strains) and gE (absent in vaccine strains) genes.
  2. Challenge Study: Nine 10-week-old cats were divided into three groups: Mock (saline control), Bartha-K61 (attenuated vaccine strain), and SD18 (highly pathogenic wild-type strain). Clinical signs, viral shedding, and pathological changes were monitored over 14 days.

Results

The survey revealed that 9.2% (5/54) of cats were PRV-positive, with three of these infected by gE-deleted vaccine strains, suggesting circulation of vaccine-derived PRV in the feline population.

In the challenge study, the wild-type SD18 strain was 100% lethal within 2–3 days. In contrast, the Bartha-K61 group showed 0% mortality but exhibited "slight" clinical signs, including anorexia, anxiety, and crying, starting around 6–7 days post-infection.

Survival rates of cats infected with wild-type (SD18) and attenuated (Bartha-K61) PRV strains.

Pathological analysis showed that the wild-type strain caused massive systemic damage, including lung hemorrhaging and organ swelling. The vaccine strain (Bartha-K61) caused minimal visible gross lesions, primarily minor kidney swelling, despite inducing neurological distress.

Gross pathological changes in organs of cats infected with different PRV strains. Arrows indicate lesions.

Furthermore, cats infected with the Bartha-K61 strain began shedding the virus 3 days post-infection through buccal, nasopharyngeal, and anal routes, indicating their potential role as secondary vectors for the virus.

Discussion

This study demonstrates that attenuated PRV vaccine strains are circulating in cats and can cause clinical illness and viral shedding. While not as lethal as wild-type PRV, these strains pose a significant biosafety risk to companion animals and potentially complicate control efforts. Limitations include the inability to isolate live virus from clinical samples and the small sample size of the challenge study. Future research is needed to understand the mechanisms of Bartha-K61 pathogenicity in cats, potentially involving impaired intra-axonal transport in the feline nervous system. These findings highlight the need for caution regarding the unintended risks of cross-species transmission of live vaccines.

Summary updated

Abstract

Pseudorabies virus (PRV) is a zoonotic agent that causes significant economic losses in animal husbandry worldwide, and <i>gE</i>-deleted vaccines play an important role in its treatment in the swine industry. However, the potential risk of attenuated PRV strains in commercial vaccines for other hosts remains unclear. Especially, cats are important companion animals for human beings. In this study, we investigated the prevalence and pathogenicity of the PRV wild strain in the cat population. We found that the occurrence of PR diseases in cats is sporadic, that the attenuated PRV strain causes slight clinical signs in cats, and that the virus is excreted 3 days post-infection. Our findings will be beneficial in furthering our understanding of the epidemiology and pathogenicity of PRV in cats and implying the great risk of RPV transmission from pigs to cats.
BibTeX
@inproceedings{tu2022assessing,
  author = {Lu Tu and Jingjie Zhao and Qiuyang Chen and Shan Zhang and Liang Lin and Xinming Tang and Shaohua Hou and Weifang Yang and Ruiying Liang},
  title = {{Assessing the Risk of Commercial Vaccines Against Pseudorabies Virus in Cats}},
  booktitle = {Frontiers in Veterinary Science},
  year = {2022},
  doi = {10.3389/fvets.2022.857834},
}
Figure